The Cancer Letter

Inside information on cancer research and drug development

In Brief

NCCN begins work on guidelines to improve cancer care in the Caribbean

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The National Comprehensive Cancer Network and the Caribbean Association for Oncology & Hematology are collaborating to develop a library of NCCN Harmonized Guidelines for the Caribbean during the CAOH Conference—Oncology.

Robert Carlson, chief executive officer of NCCN was joined at the CAOH conference by Joan McClure, senior vice president, clinical information and publications, NCCN; Ben Anderson, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Al Benson, Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Natalie Callander, University of Wisconsin Carbone Cancer Center; Wui-Jin Koh, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; James Mohler, Roswell Park Comprehensive Cancer Center; and Douglas Wood, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

They participated in a working session with local oncologists to adapt existing NCCN Clinical Practice Guidelines in Oncology and NCCN Framework for Resource Stratification of NCCN Guidelines in order to better reflect the diverse needs and resources throughout the Caribbean.

The Clinical Team was led by Kavi Capildeo, Trinidad and Tobago; Sophia Edwards-Bennett, Jamaica; Owen Gabriel, St. Lucia; Theresa Laurent, Oncology/Haematology, Barbados; Dylan Narinesingh; and Gilian Wharfe, The University of the West Indies, Jamaica.

The NCCN Harmonized Guidelines for the Caribbean will initially cover the following cancer types:

  • Breast Cancer

  • Cervical Cancer

  • Colon Cancer & Colon Cancer Screening

  • Multiple Myeloma

  • Non-Small Cell Lung Cancer

  • Prostate Cancer

  • Rectal Cancer

Table of Contents

YOU MAY BE INTERESTED IN

White House

Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
By Paul Goldberg
Capitol Hill

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
By Claire Marie Porter
Guest Editorial

Cancer research fuels life-saving work

Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 
By Ze’ev Ronai
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account